# Interactive Strength, Inc.: filings

TRNR · Nasdaq · CIK 1785056 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/trnr.md) · [Financials](/companies/trnr/financials.md) · [Filings](/companies/trnr/filings.md) · [Insiders](/companies/trnr/insiders.md)

## Reports and events: 149 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 107, 424B3 40, CORRESP 27, 4 22, UPLOAD 14, 3 13, 10-Q 11, EFFECT 9, S-1/A 8, 424B5 6, DEF 14A 6, PRE 14A 6, S-1 6, 424B4 5, 8-K/A 4, S-3/A 4, 10-K 3, D 3, DRS 3, FWP 3, NT 10-Q 3, S-3 3, 10-K/A 2, DEFA14A 2, DRSLTR 2, 3/A 1, 8-A12B 1, CERT 1, D/A 1, DRS/A 1, S-8 1, SC 13D 1, SC 13D/A 1, SC 13G 1, SC 13G/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-13 | 20:15 ET | [8-K](/filings/0001193125-26-420445.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-420445 |
| 2026-09-01 | 21:00 ET | [8-K](/filings/0001193125-26-378586.md) | 5.07 Shareholder vote results | 0001193125-26-378586 |
| 2026-08-17 | 10:05 ET | [DEF 14A](/filings/0001193125-26-353153.md) | Proxy statement, period 2026-08-14 | 0001193125-26-353153 |
| 2026-08-14 | 20:45 ET | [10-Q](/filings/0001193125-26-352477.md) | Quarterly report, period 2026-06-30 | 0001193125-26-352477 |
| 2026-08-14 | 20:31 ET | [8-K](/filings/0001193125-26-352422.md) | 3.02 Unregistered sale of equity | 0001193125-26-352422 |
| 2026-08-07 | 20:15 ET | [8-K](/filings/0001193125-26-340285.md) | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-340285 |
| 2026-07-31 | 20:15 ET | [8-K](/filings/0001193125-26-328605.md) | 3.02 Unregistered sale of equity | 0001193125-26-328605 |
| 2026-07-24 | 20:30 ET | [8-K](/filings/0001193125-26-316159.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity | 0001193125-26-316159 |
| 2026-07-09 | 21:15 ET | [8-K](/filings/0001193125-26-299839.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-299839 |
| 2026-07-07 | 20:30 ET | [8-K](/filings/0001193125-26-297535.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-297535 |
| 2026-07-01 | 21:00 ET | [8-K](/filings/0001193125-26-292779.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001193125-26-292779 |
| 2026-06-30 | 20:15 ET | [8-K](/filings/0001193125-26-290535.md) | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-290535 |
| 2026-06-09 | 20:30 ET | [8-K](/filings/0001193125-26-263835.md) | 5.07 Shareholder vote results | 0001193125-26-263835 |
| 2026-05-20 | 20:58 ET | [10-Q](/filings/0001193125-26-232775.md) | Quarterly report, period 2026-03-31 | 0001193125-26-232775 |
| 2026-05-12 | 20:14 ET | [8-K/A](/filings/0001193125-26-219465.md) | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001193125-26-219465 |
| 2026-04-24 | 20:01 ET | [DEF 14A](/filings/0001193125-26-177084.md) | Proxy statement, period 2026-04-24 | 0001193125-26-177084 |
| 2026-04-03 | 20:00 ET | [8-K](/filings/0001193125-26-142081.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-142081 |
| 2026-03-31 | 20:52 ET | [10-K](/filings/0001193125-26-134836.md) | Annual report, period 2025-12-31 | 0001193125-26-134836 |
| 2026-03-16 | 20:15 ET | [8-K](/filings/0001193125-26-108367.md) | 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-108367 |
| 2026-03-11 | 20:32 ET | [8-K](/filings/0001193125-26-102276.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-102276 |
| 2026-03-06 | 21:30 ET | [8-K](/filings/0001193125-26-096664.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-096664 |
| 2026-03-05 | 21:32 ET | [8-K](/filings/0001193125-26-094084.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-094084 |
| 2026-02-25 | 21:35 ET | [8-K](/filings/0001193125-26-071829.md) | 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-071829 |
| 2026-02-23 | 22:13 ET | [8-K](/filings/0001193125-26-064329.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-064329 |
| 2026-02-11 | 21:15 ET | [8-K](/filings/0001193125-26-046591.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity | 0001193125-26-046591 |
| 2026-01-27 | 21:30 ET | [8-K](/filings/0001193125-26-024561.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-024561 |
| 2026-01-23 | 22:15 ET | [8-K](/filings/0001193125-26-021272.md) | 3.02 Unregistered sale of equity | 0001193125-26-021272 |
| 2026-01-07 | 21:33 ET | [8-K](/filings/0001193125-26-006397.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-006397 |
| 2026-01-05 | 21:46 ET | [8-K](/filings/0001193125-26-002608.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-002608 |
| 2025-12-18 | 13:30 ET | [8-K](/filings/0001193125-25-323793.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events | 0001193125-25-323793 |
| 2025-12-12 | 21:30 ET | [8-K](/filings/0001193125-25-317646.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 2.04 Item not in the standard list; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-25-317646 |
| 2025-12-05 | 21:46 ET | [8-K](/filings/0001193125-25-309804.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity | 0001193125-25-309804 |
| 2025-11-25 | 14:00 ET | [8-K](/filings/0001193125-25-294680.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-294680 |
| 2025-11-14 | 21:36 ET | [8-K](/filings/0001193125-25-283165.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-283165 |
| 2025-11-14 | 21:28 ET | [10-Q](/filings/0001193125-25-283081.md) | Quarterly report, period 2025-09-30 | 0001193125-25-283081 |
| 2025-10-31 | 21:06 ET | [8-K](/filings/0001193125-25-260937.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-260937 |
| 2025-10-06 | 20:59 ET | [8-K](/filings/0001193125-25-232027.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity | 0001193125-25-232027 |
| 2025-10-02 | 21:04 ET | [8-K](/filings/0001193125-25-228627.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-25-228627 |
| 2025-09-30 | 21:13 ET | [8-K](/filings/0001193125-25-225252.md) | 5.07 Shareholder vote results | 0001193125-25-225252 |
| 2025-09-23 | 21:00 ET | [8-K](/filings/0001193125-25-213543.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-25-213543 |
| 2025-09-17 | 21:04 ET | [8-K/A](/filings/0001193125-25-206325.md) | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001193125-25-206325 |
| 2025-08-27 | 20:43 ET | [8-K](/filings/0000950170-25-111723.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity | 0000950170-25-111723 |
| 2025-08-18 | 20:17 ET | [DEF 14A](/filings/0000950170-25-109737.md) | Proxy statement, period 2025-08-18 | 0000950170-25-109737 |
| 2025-08-14 | 20:41 ET | [8-K](/filings/0000950170-25-109001.md) | 9.01 Financial statements and exhibits | 0000950170-25-109001 |
| 2025-08-14 | 20:27 ET | [10-Q](/filings/0000950170-25-108949.md) | Quarterly report, period 2025-06-30 | 0000950170-25-108949 |
| 2025-08-08 | 21:08 ET | [8-K](/filings/0000950170-25-106001.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0000950170-25-106001 |
| 2025-07-25 | 21:25 ET | [8-K](/filings/0000950170-25-098880.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 5.08 Item not in the standard list | 0000950170-25-098880 |
| 2025-07-11 | 20:27 ET | [8-K](/filings/0000950170-25-095305.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-25-095305 |
| 2025-07-08 | 20:09 ET | [8-K](/filings/0000950170-25-094587.md) | 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0000950170-25-094587 |
| 2025-07-02 | 21:02 ET | [8-K](/filings/0000950170-25-093152.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000950170-25-093152 |

Page 1 of 3. [Older](/companies/trnr/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.